Retrospective analysis of Ki-67 antigen expression in paraffin tissue blocks of laryngeal squamous cell carcinoma

American Journal of Otolaryngology - Head and Neck Medicine and Surgery

Volumn 24, Issue 2, 2003, Pages 106-110

  Fumic Dunkic, Lidija ^a   Katic, Vladimir ^b   Janjanin, Sasa ^b   Klapan, Ivica ^b   Simuncic, Anamarija ^b   Vcev, Aleksandar ^c  

^a Klinika za traumatologiju Zagreb   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c UNIVERSITY HOSPITAL OSIJEK   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER REGRESSION; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; LARYNX SURGERY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA;

EID: 0037347986     PISSN: 01960709     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajot.2003.17     Document Type: Article

References (42)

1. Kearsley KL, Furlong RA, Cooke MJ: An immunohistochemical assessment of cellular proliferation markers in head and neck cancers. Br J Cancer 61:821-827, 1990
2. Beahrs OH, Henson DE, Hutter RVP, et al: Manuel for Staging of Cancer. American Joint Committee on Cancer (ed 3). Philadelphia, PA, JB Lippincott Co, 1988
3. Snyderman CH, Klapan I, Milanovich M, et al: Comparison of in vivo and in vitro prostaglandin E2 production by squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 111:189-196, 1994
4. Gerdes J, Lelle RJ, Pickartz H: Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67. J Clin Pathol 39:977-980, 1986
5. Gerdes J, Li L, Schlueter C, et al: Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 138:867-873, 1991
6. Nakano T, Oka K: Differential values of Ki-67 index and mitotic index of proliferating cell population. Cancer 72:2401-2408, 1993
7. Franklin WA, McDonald GB, Stein HO: Immunohistologic demonstration of abnormal colonic crypt cell kinetics in ulcerative colitis. Hum Pathol 16:1129-1132, 1986
8. Lelle RJ, Heidenrich W, Stauch G, et al: Determinations of growth fractions in benign breast disease with monoclonal antibody Ki-67. J Cancer Res Clin Oncol 113:73-77, 1986
9. Lange A, Klimczak A, Karabon L, et al: Cytokines, adhesion molecules (E- selection and VCAM-1) and graft-versus-host disease. Arch Immunol Ther Exp (Warsz) 43:99-105, 1995
10. Murakami K, Fujioka T, Kodama R, et al: Helicobacter pylori infection accelerates human gastric mucosal cell proliferation. J Gastroenterol 32:184-188, 1997
11. Soderqvist G, Isaksson E, von Schoultz B, et al: Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am J Obstet Gynecol 176:123-128, 1997
12. Zietz C, Hotz B, Sturzl M, et al: Aortic endothelium in HIV-1 infection: chronic injury, activation and increased leukocyte adherence. Am J Pathol 149:1887-1898, 1996
13. Krenn V, Schalhorn N, Greiner A, et al: Immunohistochemical analysis of proliferating and antigen-presenting cells in rheumatoid synovial tissue. Rheumatol Int 15:239-247, 1996
14. Bouzubar N, Walker KJ, Griffiths K, et al: Blamey immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer 59:943-947, 1989
15. DiStefano D, Minazzini PL, Scucchi L: A comparative study of histopathology, hormone receptors, peanut lectin binding, Ki-67 immunostaining and nuclear organizer region association proteins in human breast cancer. Cancer 67:463-471, 1991
16. Kerns BJ, Jordan PA, Faerman LL, et al: Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis. Am J Pathol 101:192-197, 1994
17. Isola J, Kallioniemi OP, Korte JM, et al: Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: Correlation with DNA flow cytometry, biochemical receptor assay, and patient survival. J Pathol 162:295-301, 1990
18. Brown DC, Cole D, Gatter KC, et al: Carcinoma of the cervix uteri: An assessment of tumour proliferation using the monoclonal antibody KI-67. Br J Cancer 67:178-181, 1988
19. Yonemura Y, Ooyama S, Suguyama K, et al: Growth fractions in gastric carcinomas determined with monoclonal antibody Ki-67. Cancer 65:1130-1134, 1990
20. Sheperd NA, Richman PI, England J: Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations. J Pathol 155:213-219, 1988
21. Kubota Y, Petras RE, Easley KA, et al: Ki-67 determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. Cancer 70:2602-2609, 1992
22. Karamitopoulou E, Perentes E, Diamantis I, et al: Ki-67 immunorectivity in human central nervous system tumors: A study with MIB 1 monoclonal antibody on archival material. Acta Neuropathol 87:47-54, 1994
23. Kamel OW, LeBrun DP, Davis RE, et al: Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/cyclin 19A2. Am J Pathol 138:1471-1477, 1991
24. Slymen DJ, Miller TP, Lippman SM, et al: Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma. J Clin Oncol 8:986-993, 1990
25. Gatter KC, Dunnil MS, Van Muijen GN, et al: Human lung tumours may coexpress different classes of intermediate filaments. J Clin Pathol 39:950-954, 1986
26. Kaudewitz P, Braun-Falco O, Ernest M, et al: Tumor cell growth fractions in human malignant melanomas and correlation to histopathologic tumor grading. Am J Pathol 134:1063-1068, 1989
27. DAKO, Specification Sheet, Rabbit Anti-Human Ki-67 Antigen, Code No. A 047, Lot 036
28. Bourne JA: Handbook of Immunoperoxidase Staining Methods. Copenhagen, Denmark: Immunochemistry Laboratory, DAKO Corporation, 1983
29. Pulkkinen JO, Penttinen M, Jalkanen M, et al: Syndecan-1: A new prognostic marker in laryngeal cancer. Acta Otolaryngol (Stockh) 117:312-315, 1997
30. Carter RL: Pathology of squamous carcinomas of the head and neck. Curr Opin Oncol 3:305-311, 1991
31. Resnick MJ, Uhlman D, Niehans GA, et al: Cervical lymph node status and survival in laryngeal carcinoma-prognostic factors. Ann Otol Rhinol Laryngol 105:685-694, 1995
32. Zidar N, Gale N, Cor A, et al: Expression of Ki-67 antigen and proliferative cell nuclear antigen in benign and malignant epithelial lesions of the larynx. J Laryngol Otol 110:440-445, 1996
33. Youssef EM, Matsuda T, Takada N, et al: Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus. Cancer 76:358-366, 1995
34. Scotlandi K, Setra M, Manara MC, et al: Clinical relevance of Ki-67 expression in bone tumors. Cancer 75:806-814, 1995
35. Yamanaka N, Harubuchi Y, Kataura A: The prognostic value of Ki-67 antigen in non-Hodgkin lymphoma of Waldeyer's ring and the nasal cavity. Cancer 70:2342-2349, 1992
36. Wintzer HO, Zipfel I, Schulte-Monting J, et al: Ki-67 immunostaining in human breast tumors and its relation to prognosis. Cancer 67:421-428, 1991
37. Cole DJ, Brown CD, Crossly E, et al: Carcinoma of the cervix uteri: an assessment of the relationship of tumor proliferation to prognosis. Br J Cancer 65:783-795, 1992
38. Raymond WA, Leong AS-Y, Bolt JW, et al: Growth fractions in human prostatic carcinoma determined by Ki-67 immunostaining. J Pathol 156:161-167, 1988
39. Roland NJ, Caslin AW, Bowie GL, et al: Has the cellular proliferation marker Ki-67 any clinical relevance in squamous cell carcinoma of the head and neck? Clin Otolaryngol 19:13-18, 1994
40. Raybaud-Diogane H, Fortin A, Morency R, et al: Markers of radioresistance in squamous cell carcinomas of head and neck: Clinico-pathologic and immunohistochemical study. J Clin Oncol 15:1030-1038, 1997
41. Potten CS: A comprehensive review of the radiobiologic response of the murine (BDF1) small intestine - A review. Int J Radiat Biol 58:925-973, 1990
42. Weichselbaum RR, Beckett MA, Hallahan DE, et al: Molecular targets to overcome radioresistence. Semin Oncol 19:14-20, 1992